These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 16582566)

  • 1. The effects of growth hormone treatment on health-related quality of life in children.
    Sheppard L; Eiser C; Davies HA; Carney S; Clarke SA; Urquhart T; Ryder MJ; Stoner A; Wright NP; Butler G
    Horm Res; 2006; 65(5):243-9. PubMed ID: 16582566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone treatment and quality of life among survivors of childhood cancer.
    Eiser C; Vance YH; Glaser A; Galvin H; Horne B; Picton S; Stoner A; Butler G
    Horm Res; 2005; 63(6):300-4. PubMed ID: 16020938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone treatment and health-related quality of life in children and adolescents: A national, prospective, one-year controlled study.
    Butler G; Turlejski T; Wales G; Bailey L; Wright N
    Clin Endocrinol (Oxf); 2019 Aug; 91(2):304-313. PubMed ID: 31077606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
    Lagrou K; Xhrouet-Heinrichs D; Massa G; Vandeweghe M; Bourguignon JP; De Schepper J; de Zegher F; Ernould C; Heinrichs C; Malvaux P; Craen M
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Japanese version of the Quality of Life-Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA).
    Suzukamo Y; Noguchi H; Takahashi N; Shimatsu A; Chihara K; Green J; Fukuhara S
    Growth Horm IGF Res; 2006; 16(5-6):340-7. PubMed ID: 17081792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of parent and child quality of life assessments for decisions about growth hormone treatment in eligible children.
    Otero SC; Eiser C; Wright NP; Butler G
    Child Care Health Dev; 2013 Nov; 39(6):782-8. PubMed ID: 23294219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
    Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
    Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurements of quality of life in patients with growth hormone deficiency.
    Webb SM
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):52-5. PubMed ID: 19020387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of growth hormone on cognitive function.
    Ross JL
    Horm Res; 2005; 64 Suppl 3():89-94. PubMed ID: 16439850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone treatment in prepubertal children with celiac disease and growth hormone deficiency.
    Giovenale D; Meazza C; Cardinale GM; Farinelli E; Mastrangelo C; Messini B; Citro G; Del Vecchio M; Di Maio S; Possenti I; Bozzola M
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):433-7. PubMed ID: 18030209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near adult heights after growth hormone treatment in patients with idiopathic short stature or idiopathic growth hormone deficiency.
    Frindik JP; Kemp SF; Hunold JJ
    J Pediatr Endocrinol Metab; 2003 May; 16 Suppl 3():607-12. PubMed ID: 12795361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
    Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seven years of safety and efficacy of the recombinant human growth hormone Omnitrope in the treatment of growth hormone deficient children: results of a phase III study.
    Romer T; Saenger P; Peter F; Walczak M; Le Bouc Y; Khan-Boluki J; Berghout A
    Horm Res; 2009; 72(6):359-69. PubMed ID: 19844125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life in congenital, untreated, lifetime isolated growth hormone deficiency.
    Barbosa JA; Salvatori R; Oliveira CR; Pereira RM; Farias CT; Britto AV; Farias NT; Blackford A; Aguiar-Oliveira MH
    Psychoneuroendocrinology; 2009 Jul; 34(6):894-900. PubMed ID: 19181452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of quality of life on 4-year growth hormone therapy in Japanese patients with adult growth hormone deficiency: A post-marketing, multicenter, observational study.
    Ishii H; Shimatsu A; Nishinaga H; Murai O; Chihara K
    Growth Horm IGF Res; 2017 Oct; 36():36-43. PubMed ID: 28923784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
    Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
    Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of insulin-like growth factor-1 in Indian growth hormone-deficient children on growth hormone therapy.
    Ekbote VH; Rustagi VT; Khadilkar VV; Khadilkar AV; Chiplonkar SA
    Endocr Res; 2011; 36(3):109-15. PubMed ID: 21736493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption.
    Svensson J; Mattsson A; Rosén T; Wirén L; Johannsson G; Bengtsson BA; Koltowska Häggström M;
    Growth Horm IGF Res; 2004 Jun; 14(3):207-15. PubMed ID: 15125882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.